Soluble epoxide hydrolase in atherosclerosis.

Journal Information

Full Title: Curr Atheroscler Rep

Abbreviation: Curr Atheroscler Rep

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure Y-X Wang and L-N Zhang were employees of Arête Therapeutics, Inc., a pharmaceutical company developing new class of sEH inhibitors for human therapeutics. BD Hammock and A Ulu are employees of the University of California, which has intellectual property in this area."

Evidence found in paper:

"Partial support for this work came from grants R01 ES002710 and P42 ES004699 from NIEHS and R01 HL059699 from NIH/NHLBI. The authors would like to thank Dr. Euan MacIntyle for critically reviewing this manuscript."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025